Rapid bladder cancer test NMP22®
proteinurinestrip

Rapid bladder cancer test - NMP22® - Abbott - protein / urine / strip
Rapid bladder cancer test - NMP22® - Abbott - protein / urine / strip
Add to favorites
Compare this product
 

Characteristics

Applications
bladder cancer
Tested parameter
protein
Sample type
urine
Format
strip
Result display time

30 min

Sensitivity

99 %

Description

The Alere NMP22® BladderChek® Test is a fast, easy to use and non-invasive test that aids in the diagnosis and monitoring of bladder cancer, in conjunction with standard diagnostic procedures. With results in 30 minutes at the point-of-care, results can be delivered to patients during the same office visit, allowing a rapid and cost-effective aid in the detection of bladder cancer in patients at risk. BENEFITS CE-marked and CLIA-waived. FDA cleared in the US for professional point-of-care and prescription home use. Ability to test patients at risk for bladder cancer. Easy testing process, only requiring 4 drops of urine to run the test. Fast results in 30 minutes, allowing consultation during the same visit. An ideal adjunct marker to cystoscopy as found in one study: 99% NPV overall when combined with cystoscopy, the most effective diagnostic combination for ruling out bladder cancer.1,2

Catalogs

No catalogs are available for this product.

See all of Abbott‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.